Relationships between morphology, dissemination, migration, and prostaglandin E2 secretion by cloned variants of Lewis lung carcinoma
- PMID: 3860290
Relationships between morphology, dissemination, migration, and prostaglandin E2 secretion by cloned variants of Lewis lung carcinoma
Abstract
Lewis lung carcinoma cells (LLC) were isolated and cloned from metastatic lung nodules of C57BL/6 mice or from a cultured parental LLC line. Their dissemination abilities were defined in vivo by their capacities to disseminate to the lungs following s.c. or i.v. injection into mice and in an in vitro model for tumor dissemination by their ability to migrate out of glass capillary tubes. Cloned LLC cells with an enhanced dissemination capacity exhibited a rounded morphology, were nonadherent during in vitro culture, and readily migrated out of capillary tubes. In contrast, clones not capable of dissemination were adherent and spread during in vitro culture and did not migrate out of capillary tubes. Production of prostaglandin E2 by these clones was measured by a radioimmunoassay. An inverse relationship was observed between the extent of migration and dissemination of clones and their ability to secrete prostaglandin E2 in vitro and in vivo. However, the prostaglandin E2 did not regulate the migration-dissemination capacities of LLC clones as inhibiting prostaglandin synthesis did not alter their capacity to migrate in vitro or to lodge in the lungs following i.v. inoculation into mice.
Similar articles
-
Effect of prostaglandin E2-producing nonmetastatic Lewis lung carcinoma cells on the migration of prostaglandin E2-responsive metastatic Lewis lung carcinoma cells.Cancer Res. 1987 Jul 15;47(14):3679-83. Cancer Res. 1987. PMID: 3109729
-
Association of a functional prostaglandin E2-protein kinase A coupling with responsiveness of metastatic Lewis lung carcinoma variants to prostaglandin E2 and to prostaglandin E2-producing nonmetastatic Lewis lung carcinoma variants.Cancer Res. 1990 May 15;50(10):2973-8. Cancer Res. 1990. PMID: 2159367
-
Enhancement of Lewis lung carcinoma cell migration by prostaglandin E2 produced by macrophages.Cancer Res. 1986 Jan;46(1):160-4. Cancer Res. 1986. PMID: 3455665
-
Prostaglandin E2 production by EL 4 leukemia cells from C57BL/6 mice: mechanism for tumor dissemination.J Natl Cancer Inst. 1985 Jan;74(1):191-5. J Natl Cancer Inst. 1985. PMID: 3855478
-
Prostaglandins and metastasis.Symp Fundam Cancer Res. 1983;36:123-31. Symp Fundam Cancer Res. 1983. PMID: 6206537 Review.
Cited by
-
Antibodies to colony-stimulating factors block Lewis lung carcinoma cell stimulation of immune-suppressive bone marrow cells.Cancer Immunol Immunother. 1991;33(3):146-52. doi: 10.1007/BF01756134. Cancer Immunol Immunother. 1991. PMID: 1675153 Free PMC article.
-
Polyamine deprivation prevents the development of tumour-induced immune suppression.Br J Cancer. 1997;76(3):365-70. doi: 10.1038/bjc.1997.391. Br J Cancer. 1997. PMID: 9252204 Free PMC article.
-
Protein phosphatase-2A modulates the serine and tyrosine phosphorylation of paxillin in Lewis lung carcinoma tumor variants.Clin Exp Metastasis. 2002;19(5):409-15. doi: 10.1023/a:1016385027013. Clin Exp Metastasis. 2002. PMID: 12198769
-
Substrate adhesiveness and experimental metastatic potential of rat ascites hepatoma AH7974-derived variant sublines.Clin Exp Metastasis. 1992 Jul;10(4):225-38. doi: 10.1007/BF00133558. Clin Exp Metastasis. 1992. PMID: 1377614
-
Influence of lipid diets on the number of metastases and ganglioside content of H59 variant tumors.Clin Exp Metastasis. 1997 Jul;15(4):410-7. doi: 10.1023/a:1018402321818. Clin Exp Metastasis. 1997. PMID: 9219729
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical